Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen

OBJECTIVES: The optimal antiretroviral therapy for patients with the M184V/I mutation is not known. The primary objective of this study was to determine the efficacy of various antiretroviral therapies in patients with HIV and the M184V/I mutation based on the number of active antiretroviral agents....

Descripción completa

Detalles Bibliográficos
Autores principales: Mouradjian, Mallory T, Heil, Emily L, Sueng, Hyunuk, Pandit, Neha Sheth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509719/
https://www.ncbi.nlm.nih.gov/pubmed/33014372
http://dx.doi.org/10.1177/2050312120960570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509719/
https://www.ncbi.nlm.nih.gov/pubmed/33014372
http://dx.doi.org/10.1177/2050312120960570

Ejemplares similares